Work

Phase II study of antidisialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma (AOST1421): A report from the Children’s Oncology Group.

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.15_suppl.10508

Authors: Pooja Hingorani, Mark D. Krailo, Allen Buxton, Paul R. Hutson, Justin Davis, Katherine A. Janeway, Richard Greg Gorlick, Michael Isakoff

Institutions: The University of Texas MD Anderson Cancer Center, Children's Oncology Group, University of Wisconsin–Madison, Dana-Farber Cancer Institute, Connecticut Children's Medical Center

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

OpenAlex ID: W3032341827

Cites:

Cited by: 17

Related to: 10